Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
1745studies shown
Showing 1,237-1,248 of 1,745
Drug study icon
TerminatedEUCTR 2012-001357-10

Once a Day, TAK-375 (Ramelteon) Tablet for Depression

This study was terminated in the United Kingdom, in Germany, in Czechia, .... It is testing Once a Day, TAK-375 (Ramelteon) Tablet for Depression.

In United Kingdom
Depression, BipolarityOther
Countries
United Kingdom, Germany, Czechia, ...
Sponsor
Takeda Global Research & Development Centre (Europe) Ltd (TGRD)
Condition
Depression, Bipolarity
Drug study icon
CompletedNCT01209039

A Repeat Dose Positron Emission Tomography Study With GSK1144814

This summary needs review. Please check the official study record and contact the research team for details.

In United Kingdom
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
United Kingdom
Sponsor
GlaxoSmithKline
Condition
Schizophrenia
Drug study icon
CompletedNCT05841030

A Study in people with Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)

This study is completed in the United States, in France, in Canada, .... It focuses on depression.

In United Kingdom
DepressionOtherFrom 18 Years to 74 Years
Countries
United States, France, Canada, ...
Sponsor
Janssen Research & Development, LLC
Condition
Depression
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.